From: Barry Hardy (barry.hardy$##$tiscalinet.ch)
Date: Tue Jun 27 2006 - 09:07:13 EDT
The eCheminfo Community of Practice InterAction Meeting "Latest Advances in
Drug Discovery Design & Planning Methods" will take place 16-19 October
2006, Bryn Mawr, Philadelphia, USA
Program themes include Structure-based Drug Design, Screening & Docking,
Cheminformatics & Modeling supporting Medicinal Chemistry, Pharmacophores,
Metabolomics, Quantum Biochemistry, Knowledge Management, Electronic Lab
Notebooks, Critical Path Innovation in Drug Development, Biomarkers,
Predictive Toxicology & ADME. In addition to morning presentations and
panel discussions, workshops will run each afternoon expanding on the
discussion of topics and methods and working through the application of new
methods and software to drug discovery & development problems, with bbq,
social activity and poster sessions running on campus during the evenings.
The preliminary program and schedule is available at:
http://www.echeminfo.com/COMTY_conferences/
Reduced rates apply for early registration through 30 June. Academic
discounts apply.
All registrants are eligible to submit an abstract (ca. 300 words) for the
poster sessions.
Please address any questions related to the conference, exhibition or
workshop program to me. Registration enquiries should be directed to
eCheminfo [at] douglasconnect.com
best regards
Barry Hardy
eCheminfo Community of Practice
Douglas Connect
Baermeggenweg 14, Zeiningen
CH-4314, Switzerland
Tel: +41 61 851 0170
Confirmed Speakers at the Bryn Mawr meeting include:
Frank Hollinger (Locus Pharmaceuticals), Erin Duffy (Rib-X), Mike Malams
(Wyeth), Debananda Das (NCI), Max Cummings (Johnson & Johnson PR&D), Lance
Westerhoff (QuantumBio), Jose Duca (Schering-Plough), Osman Guner
(Turquoise Consulting), Hege Beard (Schrodinger), Stan Young (NISS), John
Irwin (UCSF), William Douglas Figg (NCI), Daryll Reid (Simbiosys), Gregory
Warren (GlaxoSmithKline), Deepak Bandyopadhyay (Johnson & Johnson PR&D),
Paul Hawkins (OpenEye), Chris Cooper (BMS), James Arnold (Astra-Zeneca),
Phil Edwards (Astra-Zeneca), Pete Connolly (Johnson & Johnson PR&D),
Dimitris Agrafiotis (Johnson & Johnson PRD), Jim Wikel (Coalesix), Tudor
Oprea (Univ. New Mexico), Alex Tropsha (UNC), Curt Breneman (RPI), Sanji
Bhal (ACD/Labs), Michael Bolger (Simulations Plus), Bob Clark (Tripos),
Gilles Klopman (Multicase), Navita Mallalieu (Roche Pharmaceuticals),
Deepak Bandyopadhyay (Johnson & Johnson PR&D), Zentam Tsuchihashi (BMS),
Peter Henstock (Pfizer), Darius Dziuda (Multivariate bioMarkers Discovery),
Keith Elliston (Genstruct), Michael Liebman (Windber Research Institute),
Jonathan Sheldon (InforSense), Duane Shugars (Concentia Digital), Jian Wang
(Biofortis), Peter Gates (Johnson & Johnson PR&D), Barry Hardy (Douglas
Connect), Dennis Underwood (Praxeon), Jeff Spitzner (Rescentris), David
Mosenkis (Spotfire), Joel Hoffman (IntraSphere), Delia Wolf (Harvard
Medical School), Craig Liddell (Realtime Science), Joseph Bitran
(Enterprizer), Alvin Berger (Metabolon), Gregory Banik (Bio-RAD), George
Harrigan (Monsanto), Rick Beger (NCTR, FDA), Don Robertson (Pfizer), Teresa
Garret (Duke University), Laszlo Boros (SIDMAP), Bruce Kristal (Cornell
University), Andrew Lane (JG Brown Cancer Center, U. Louisville), Oliver
Fiehn (UC Davis Genome Center), Susan Connor (Glaxo SmithKline)
_______________________________________________
ORGLIST - Organic Chemistry Mailing List
Website / Archive / FAQ: http://www.orglist.net
To post a message (TO EVERYBODY) send to everybody$##$orglist.net
To unsubscribe, send to everybody-request$##$orglist.net the message: unsubscribe your_orglist_password your_address
This archive was generated by hypermail 2.1.4 : Tue Feb 13 2007 - 14:17:01 EST